Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Alok Khorana, MD
How should a clinician respond when a patient presents with an unprovoked venous thromboembolism? Clots of indeterminant cause are common, and epidemiological studies have shown that some are associated with undiagnosed cancer. While an aggressive and extensive diagnostic workup might seem like a logical course, especially with a worried patient, does this “do-more” approach lead to earlier cancer detection and more effective treatment?
A recent trial involving nine Canadian medical centers compared the results of a limited screening strategy for unprovoked clot patients with the outcomes of a more extensive approach that added CT scans of the abdomen and pelvis. Cleveland Clinic oncologist Alok Khorana, MD, discusses the trial’s findings and their implications for clinical decisionmaking in a New England Journal of Medicine editorial.
Read “Cancer Workup after Unprovoked Clot — Less Is More” by Dr. Khorana of Cleveland Clinic’s Department of Hematology and Oncology.
Photo credit: ©Russell Lee
Advertisement
Advertisement
First-of-its-kind research investigates the viability of standard screening to reduce the burden of late-stage cancer diagnoses
Global R&D efforts expanding first-line and relapse therapy options for patients
Study demonstrates ability to reduce patients’ reliance on phlebotomies to stabilize hematocrit levels
A case study on the value of access to novel therapies through clinical trials
Findings highlight an association between obesity and an increased incidence of moderate-severe disease
Cleveland Clinic Cancer Institute takes multi-faceted approach to increasing clinical trial access 23456
Key learnings from DESTINY trials
Overall survival in patients treated since 2008 is nearly 20% higher than in earlier patients